In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

The creatinine to uromodulin ratio in serum predicts major cardiovascular events independently from the presence of type 2 diabetes

Session Poster session 7

Speaker Christoph Saely

Event : ESC Congress 2017

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Acute Coronary Syndromes: Biomarkers
  • Session type : Poster Session

Authors : A Leiherer (Feldkirch,AT), A Muendlein (Feldkirch,AT), CH Saely (Triesen,LI), J Ebner (Feldkirch,AT), EM Brandtner (Feldkirch,AT), A Schuler (Feldkirch,AT), P Schwerzler (Triesen,LI), A Mader (Triesen,LI), P Fraunberger (Feldkirch,AT), H Drexel (Philadelphia,US)

A. Leiherer1 , A. Muendlein1 , C.H. Saely2 , J. Ebner1 , E.M. Brandtner1 , A. Schuler3 , P. Schwerzler2 , A. Mader2 , P. Fraunberger4 , H. Drexel5 , 1VIVIT Institute - Feldkirch - Austria , 2Private University of the Principality of Liechtenstein - Triesen - Liechtenstein , 3Academic Teaching Hospital, Department of Medicine and Cardiology - Feldkirch - Austria , 4Medical Central Laboratory - Feldkirch - Austria , 5Drexel University College of Medicine - Philadelphia - United States of America ,

European Heart Journal ( 2017 ) 38 ( Supplement ), 1324-1325

Introduction: Low concentrations of the kidney protein uromodulin are associated with type 2 diabetes (T2DM) and with chronic kidney disease (CKD). The serum creatinine to uromodulin ratio recently has attracted interest as a marker of CKD.

Purpose: The purpose of this study was to investigate whether the creatinine to uromodulin ratio also is associated with the risk for major cardiovascular events.

Methods: We measured uromodulin in 529 coronary patients and prospectively recorded major cardiovascular events (coronary death, fatal and non-fatal ischemic stroke, and non-fatal myocardial infarction) over up to 8 years.

Results: During follow-up, a total of 91 major cardiovascular events occurred. The incidence of major cardiovascular events was significantly higher in patients with T2DM (n=141) than in those who did not have diabetes (25.4% vs. 14.6%; p=0.004). The creatinine to uromodulin ratio significantly predicted major cardiovascular events both univariately (HR 1.37 [95% CI 1.21–1.56], p<0.001) and after multivariate adjustment including the presence of T2DM (HR 1.36 [CI 1.18–1.58], p<0.001).

Conclusion: In conclusion, this study for the first time shows that the serum creatinine to uromodulin ratio predicts major cardiovascular events independently from conventional risk factors including the presence of T2DM. Given that the biological role of uromodulin is still elusive this result appears important and may stimulate future research on uromodulin.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are